Enzymology of Cancer Cells

New England Journal of Medicine

Volumn 296, Issue 10, 1977, Pages 541-551

  Weber, George ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ENZYME;

CANCER CELL; CELL METABOLISM; DIAGNOSIS; GLYCOLYSIS; HISTOLOGY; IN VITRO STUDY; METHODOLOGY; PENTOSE PHOSPHATE CYCLE; REVIEW;

ANIMAL; CARCINOMA, HEPATOCELLULAR; GLUCONEOGENESIS; GLYCOLYSIS; HUMAN; LIVER; LIVER NEOPLASMS; LIVER REGENERATION; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; PENTOSEPHOSPHATES; PURINES; PYRIDINES; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0017580461     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM197703102961005     Document Type: Review

References (72)

1. Weber G: Regulation of pyruvate kinase. Adv Enzyme Regul 7: 15–40, 1969
2. Taylor CB, Morris HP, Weber G: A comparison of the properties of pyruvate kinase from hepatoma 3924A, normal liver and muscle. Life Sci 8: 635–644, 1969
3. Criss WE, Litwack G, Morris HP, et al: Adenosine triphosphate: adenosine monophosphate phosphotransferase isozymes in rat liver and hepatomas. Cancer Res 30: 370–375, 1970
4. Criss WE: A review of isozymes in cancer. Cancer Res 31: 1523–1542, 1971
5. Warburg O: On the origin of cancer cells. Science 123: 309–314, 1956
6. Weber G, Morris HP, Love WC, et al: Comparative biochemistry of hepatomas. II. Isotope studies of carbohydrate metabolism in Morris hepatoma 5123. Cancer Res 21: 1406–1411, 1961
7. Lo C, Cristofalo VJ, Morris HP, et al: Studies on respiration and glycolysis in transplanted hepatic tumors of the rat. Cancer Res 28: 1–10, 1968
8. Weinhouse S: Glycolysis, respiration, and anomalous gene expression in experimental hepatomas: G.H.A. Clowes Memorial Lecture. Cancer Res 32: 2007–2016, 1972
9. Weber G, Stubbs M, Morris HP: Metabolism of hepatomas of different growth rates in situ and during ischemia. Cancer Res 31: 2177–2183, 1971
10. Weber G, Cantero A: Glucose-6-phosphatase activity in normal, precancerous and neoplastic tissues. Cancer Res 15: 105–108, 1955
11. Shonk CE, Morris HP, Boxer GE: Patterns of glycolylic enzymes in rat liver and hepatoma. Cancer Res 25: 671–676, 1965
12. Sweeney MJ, Ashmore J, Morris HP, et al: Comparative biochemistry of hepatomas. IV. Isotope studies of glucose and fructose metabolism in liver tumors of different growth rates. Cancer Res 23: 995–1002, 1963
13. Shatton JB, Morris HP, Weinhouse S: Kinetic, electrophoretic, and chromatographic studies on glucose-ATP phosphotransferase in rat hepatomas. Cancer Res 29: 1161–1172, 1969
14. Weinhouse S, Shatton JB, Criss WE, et al: Isozymes in relation to differentiation in transplantable rat hepatomas, Isozymes and Enzyme Regulation in Cancer. Edited by S Weinhouse, T Ono. Gann Monograph Series, Vol 13, 1972, pp 1–17
15. Horecker BL: Pentose metabolism in bacteria, Ciba Lectures in Microbial Biochemistry. New York, Wiley, 1962, p 30
16. Gumaa KA, McLean P: The pentose phosphate pathway of glucose metabolism: enzyme profiles and transient and steady-state content of intermediates of alternative pathways of glucose metabolism in Krebs ascites cells. Biochem J 115: 1009–1029, 1969
17. Henderson JF: Regulation of purine biosynthesis (ACS Monograph 170). Washington, DC, American Chemical Society, 1972
18. Henderson JF, Paterson ARP: Nucleotide Metabolism: An introduction. New York, Academic Press, 1973
19. Heinrich PC, Morris HP, Weber G: Behavior of transaldolase (EC 2.2.1.2) and transketolase (EC 2.2.1.1) activities in normal, neoplastic, differentiating, and regenerating liver. Cancer Res 36: 3189–3197, 1976
20. Heinrich: Increased PRPP synthetase activity in rapidly growing hepatomas. FEBS Lett 42: 145–148, 1974
21. LePage GA, Loo TL: Purine antagonists, Cancer Medicine. Edited by JF Holland, E Frei III. Philadelphia, Lea and Febiger, 1973, pp 754–768
22. Wyngaarden JB, Kelley WN: Disorders of purine and pyrimidine metabolism, The Metabolic Basis of Inherited Disease. Second edition. Edited by JB Stanbury, JB Wyngaarden, DS Fredrickson. New York, McGraw-Hill, 1966, pp 889–991
23. Caskey CT, Ashton DM, Wyngaarden JB: The enzymology of feedback inhibition of glutamine phosphoribosylpyrophosphate amidotransferase by purine ribonucleotides. J Biol Chem 239: 2570–2579, 1964
24. Prajda N, Katunuma N, Morris HP, et al: Imbalance of purine metabolism in hepatomas of different growth rates as expressed in behavior of glutamine-phosphoribosylpyrophosphate amidotransferase (amidophosphoribosyltransferase, EC 2.4.2.14). Cancer Res 35: 3061–3068, 1975
25. Weber G, Prajda N, Williams JC: Biochemical strategy of the cancer cell: malignant transformation-linked enzymatic imbalance. Adv Enzyme Regul 13: 3–25, 1975
26. De Lamirande G, Allard C, Cantero A: Purine-metabolizing enzymes in normal rat liver and Novikoff hepatoma. Cancer Res 18: 952–958, 1958
27. Bergel F: Chemistry of Enzymes in Cancer. Springfield, Illinois, CC Thomas, 1961
28. Wheeler GP, Alexander JA, Morris HP: Synthesis of purines and nucleic acids and catabolism of purines by rat liver and hepatomas. Adv Enzyme Regul 2: 347–369, 1964
29. Jackson RC, Morris HP, Weber G: Neoplastic transformation-linked alterations in adenylosuccinate synthetase activity. Biochem Biophys Res Commun 66: 526–532, 1975
30. Jackson: Increased adenylosuccinase activity in hepatomas and kidney tumors. Life Sci 18: 1043–1048, 1976
31. Jackson RC, Weber G, Morris HP: IMP dehydrogenase: an enzyme linked with proliferation and malignancy. Nature 256: 331–333, 1975
32. Baker BR: Design of Active-Site-Directed Irreversible Enzyme Inhibitors. New York, Wiley, 1967
33. Balis ME: Antagonists and Nucleic Acids. Amsterdam, North-Holland Publishing, 1968
34. Bucher NLR: Experimental aspects of hepatic regeneration. N Engl J Med 277: 686–696, 738–746, 1967
35. Bucher NLR, Malt RA: Regeneration of Liver and Kidney. Boston, Little, Brown, 1971
36. Weber G: Biochemical strategy of the regenerating liver cell, Liver Regeneration after Experimental Injury. Edited by R Lesch, W Reutter. New York, Stratton, 1975, pp 103–118
37. Idem: Ordered and specific pattern of gene expression in differentiating and in neoplastic cells, Differentiation and Control of Malignancy of Tumor Cells. Edited by W Nakahara, T Ono, T Sugimura, et al. Baltimore, University Park Press, 1974, pp 151–180
38. Busch H: The Molecular Biology of Cancer. New York, Academic Press, 1974
39. Fenselau A, Wallis K, Morris HP: Acetoacetate coenzyme A transferase activity in rat hepatomas. Cancer Res 35: 2315–2320, 1975
40. Morris HP: Biological and biochemical characteristics of transplantable hepatomas, Handbuch der Allgemeinen pathologic. Vol 6, Part 7. Tumors III. Berlin, Springer-Verlag, 1975, pp 278–334
41. Kovalszky I, Jeney A, Asbot R, et al: Biochemistry and enzyme induction in MC-29 virus-induced transplantable avian hepatoma. Cancer Res 36: 2140–2145, 1976
42. Lea MA, Convery HJH, Stamm NB, et al: Carbohydrate metabolism and DNA synthesis in kidney tumors. Proc Am Assoc Cancer Res 8: 39, 1967
43. Weber G, Cantero A: Human liver enzymes of glucose-6-phosphate utilization. Science 126: 977–978, 1957
44. Weber G, Malt RA, Glover JL, et al: Biochemical basis of malignancy in man, Biological Characterization of Human Tumours. Amsterdam, Excerpta Medica, 1976, pp 60–72
45. Mayr E: Populations, Species, and Evolution. Cambridge, Harvard University Press, 1971, p 2
46. Medawar PB: Induction and Intuition in Scientific Thought. London, Methuen and Company, 1969, p 51
47. Popper KR: The Logic of Scientific Discovery. New York, Harper and Row, 1968, p 40
48. Miyaji H, Morris HP, Wagner BP: Histological study of some primary and transplantable hepatic tumors in rats, Methods in Cancer Research 4. Edited by H Busch. New York, Academic Press, 1968, pp 153–178
49. Hruban Z, Morris HP, Mochizuki Y, et al: Light microscopic observations of Morris hepatomas. Cancer Res 31: 752–762, 1971
50. Dalton AJ: An electron microscopical study of a series of chemically induced hepatomas, Cellular Control Mechanisms and Cancer. Edited by P Emmelot, O Mühlbock. Amsterdam, Elsevier, 1964, pp 211–225
51. Nowell PC, Morris HP, Potter VR: Chromosomes of “minimal deviation” hepatomas and some other transplantable rat tumors. Cancer Res 27: 1565–1579, 1967
52. Nowell PC, Morris HP: Chromosomes of “minimal deviation” hepatomas: a further report on diploid tumors. Cancer Res 29: 969–970. 1969
53. Busch H, Hodnett JL, Morris HP, et al: Isolation of nuclei and nucleoli of Morris hepatoma cells, Methods in Cancer Research 4. Edited by H Busch. New York, Academic Press, 1968, pp 179–189
54. Grunicke H, Potter VR, Morris HP: Comparative studies on nuclei and chromatin of hepatomas and rat liver. Cancer Res 30:776–787, 1970
55. Pedersen PL, Greenawalt JW, Chan TL, et al: A comparison of some ultrastructural and biochemical properties of mitochondria from Morris hepatomas 9618A, 7800, and 3924A. Cancer Res 30: 2620–2626, 1970
56. Sasaki T, Morris HP, Baserga R: The cell cycles of three transplantable Morris hepatomas. Cancer Res 30: 788–793, 1970
57. Looney WB, Mayo AA, Janners MY, et al: Cell proliferation and tumor growth in hepatomas 3924A. Cancer Res 31: 821–825, 1971
58. Lea MA, Sasovetz D, Musella A, et al: Effects of hydroxyurea and 6-mercaptopurine on growth and some aspects of carbohydrate metabolism in regenerating and neoplastic liver. Cancer Res 30: 1994–1999, 1970
59. Ohe K, Morris HP, Weinhouse S: β-Hydroxybutyrate dehydrogenase activity in liver and liver tumors. Cancer Res 27: 1360–1371, 1967
60. Sabine JR, Abraham S, Morris HP, et al: Defective dietary control of fatty acid metabolism in four transplantable rat hepatomas: numbers 5123C, 7793, 7795, and 7800. Cancer Res 28: 46–51, 1968
61. Siperstein MD,Gyde AM, Morris HP: Loss of feedback control of hydroxymethylglutaryl coenzyme A reductase in hepatomas. Proc Natl Acad Sci USA 68: 315–317, 1971
62. Goldfarb S, Pitot HC: The regulation of β-hydroxy-β-methylglutaryl coenzyme A reductase in Morris hepatoma 5123C, 7800 and 9618A. Cancer Res 31: 1879–1882, 1971
63. Katunuma N, Kuroda Y, Sanada Y, et al: Anomalous distribution of glutaminase isozyme in various hepatomas. Adv Enzyme Regul 8: 281–287, 1970
64. Linder-Horowitz M, Knox WE, Morris HP: Glutaminase and growth rates of rat hepatomas. Cancer Res 29: 1195–1199, 1969
65. Linder M, Munro HN, Morris HP: Rat ferritin isoproteins and their response to iron administration in a series of hepatic tumors and in normal and regenerating liver. Cancer Res 30: 2231–2239, 1970
66. Borek E: Methylation reactions as possible control factors in protein synthesis, Exploitable Molecular Mechanisms and Neoplasia. Baltimore, Williams and Wilkins, 1969, pp 165–188
67. Paik WK, Lee HW, Morris HP: Protein methylases in hepatomas. Cancer Res 32: 37–40, 1972
68. Williams-Ashman HG, Coppoc GL, Schenone A, et al: Aspects of polyamine biosynthesis in normal and malignant eukaryotic cells, Polyamines in Normal and Neoplastic Growth. Edited by DH Russell. New York, Raven Press, 1973, pp 181–197
69. Farina FA, Adelman RC, Lo CH, et al: Metabolic regulation and enzyme alterations in the Morris hepatomas. Cancer Res 28: 1897–1900, 1968
70. Potter VR, Watanabe M, Pitot HC, et al: Systematic oscillations in metabolic activity in rat liver and hepatomas: survey of normal diploid and other hepatoma lines. Cancer Res 29: 55–78, 1969
71. Levitan IB, Morris HP, Webb TE: Tyrosine transaminase induction: differential effect of 5-azacytidine on liver and hepatoma 5123D. Biochim Biophys Acta 240: 287–295, 1971
72. Weber G, Jackson RC, Williams JC, et al: Enzymatic markers of neoplastic transformation and regulation of purine and pyrimidine metabolism. Adv Enzyme Regul 15: 53–77, 1977